These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1406 related items for PubMed ID: 10202164

  • 1. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.
    N Engl J Med; 1999 Apr 15; 340(15):1137-43. PubMed ID: 10202164
    [Abstract] [Full Text] [Related]

  • 2. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 3. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S.
    N Engl J Med; 1999 Apr 15; 340(15):1144-53. PubMed ID: 10202165
    [Abstract] [Full Text] [Related]

  • 4. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 15; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 5. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 15; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 6. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 15; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 7. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1522-8. PubMed ID: 19231106
    [Abstract] [Full Text] [Related]

  • 8. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Aug 01; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
    Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B.
    Gynecol Oncol; 1994 Mar 01; 52(3):326-31. PubMed ID: 8157190
    [Abstract] [Full Text] [Related]

  • 10. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 11. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M, Xu HD, Pan SD, Lin S, Yue JH, Liu JR.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):966-71. PubMed ID: 22138462
    [Abstract] [Full Text] [Related]

  • 12. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M, Cowen D, Viens P, Noirclerc M, Perez T, Gouvernet J, Delpero JR, Gamerre M, Boubli L, Houvenaeghel G.
    Gynecol Oncol; 1994 Jul 01; 54(1):68-75. PubMed ID: 8020842
    [Abstract] [Full Text] [Related]

  • 13. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY, Li LY, Shu KY, Pan M, Li HP, Luo B.
    Ai Zheng; 2008 Sep 01; 27(9):942-6. PubMed ID: 18799032
    [Abstract] [Full Text] [Related]

  • 14. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM, Gorla GR, Garg M, Anderson PS, Fields AL, Runowicz CD, Goldberg GL, Vikram B.
    Cancer; 2003 Apr 01; 97(7):1781-8. PubMed ID: 12655536
    [Abstract] [Full Text] [Related]

  • 15. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K, Jassem J.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):814-21. PubMed ID: 15465198
    [Abstract] [Full Text] [Related]

  • 16. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, Monk BJ, O'Connor DM.
    J Clin Oncol; 2005 Nov 20; 23(33):8289-95. PubMed ID: 16230678
    [Abstract] [Full Text] [Related]

  • 17. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 20; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 18. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A.
    Gynecol Oncol; 1999 Jul 20; 74(1):30-7. PubMed ID: 10385548
    [Abstract] [Full Text] [Related]

  • 19. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.
    Gynecol Oncol; 2005 Feb 20; 96(2):490-5. PubMed ID: 15661240
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 20; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.